Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling

Constitutive activation of STING by gain-of-function mutations triggers manifestation of the systemic autoinflammatory disease STING-associated vasculopathy with onset in infancy (SAVI). In order to investigate the role of signaling by tumor necrosis factor (TNF) in SAVI, we used pharmacological inhibition and genetic inactivation of TNF receptors 1 and 2 in murine SAVI, which is characterized by T cell lymphopenia, inflammatory lung disease and neurodegeneration. Pharmacologic inhibition of TNF signaling improved T cell lymphopenia, but had no effect on interstitial lung disease. Genetic inactivation of TNFR1 and TNFR2, however, rescued the loss of thymocytes, reduced interstitial lung disease and neurodegeneration. Furthermore, genetic inactivation of TNFR1 and TNFR2 blunted transcription of cytokines, chemokines and adhesions proteins, which result from chronic STING activation in SAVI mice. In addition, increased transendothelial migration of neutrophils was ameliorated. Taken together, our results demonstrate a pivotal role of TNFR-signaling in the pathogenesis of SAVI in mice and suggest that available TNFR antagonists could ameliorate SAVI in patients.

Graphic Abstract

REVIEW COMMONS

IMPORTANT

• Manuscripts submitted to Review Commons are peer reviewed in a journal-agnostic way.

• Upon transfer of the peer reviewed preprint to a journal, the referee reports will be available in full to the handling editor.

• The identity of the referees wiil NOT be communicated to the authors unless the reviewers choose to sign their report.

• The identity of the referee wi1l be confidentially disclosed to any affiliate journals to which the manuscript is transferred.

GUIDELINES

• For reviewers: https://www.reviewcommons.org/reviewers

• For authors: https://www.reviewcommons.org/authors

CONTACT

• The Review Commons office can be contacted directly at: office@reviewcommons.org